Flow Imaging Microscopy Market to Worth USD 49.23 Million by 2023

The global flow imaging microscopy market is projected to reach USD 49.23 million by 2023 from USD 31.67 million in 2018, at CAGR of 9.2 percent. Some of the major factors driving this market are increasing R&D investments by pharmaceutical and biotechnology firms and the proven advantages of flow imaging microscopy over other particle size analyzers. On the basis of sample type, the global flow imaging microscopy market is divided into biologics, small molecules, and other sample types. In 2018, the biologics segment is expected to grow at the highest CAGR in the flow imaging microscopy market. This growth can be attributed to the implementation of flow imaging microscopy in biotechnology firms after FDA recommendation, its ease of use, superior detection of near-transparent particles, and flexibility in characterizing different particles from a heterogeneous sample in biologics-based formulations. On the basis of end user, the global flow imaging microscopy market is divided into pharmaceutical and biotechnology companies, and other end users.

In 2018, the other end users segment is expected to grow at the highest CAGR in the global flow imaging microscopy market. With the growing focus on the outsourcing of the R&D and manufacturing of pharmaceutical and biotechnology products, the CROs and CMOs market in other end users segment is expected to witness significant growth. The Asia-Pacific market is projected to register the highest growth rate primarily due to the increasing outsourcing of drug discovery and development activities to CROs in countries such as China, Singapore, Japan, and South Korea. This is one of the major factors driving the growth of the flow imaging microscopy market in the Asia-Pacific. The key players in the global flow imaging microscopy market are ProteinSimple (US), Fluid Imaging Technologies (US), Occhio (Belgium), and Fritsch (Germany). – MarketsandMarkets